Sanofi-Aventis Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Sanofi-Aventis on March 28, 2011. The filing serves to incorporate an Underwriting Agreement dated March 22, 2011, by reference into the Company's Registration Statement on Form F-3 (Registration No. 333-165479). The document relates to a debt offering facilitated by underwriters including BNP Paribas Securities Corp., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, and SG Americas Securities, LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt levels, or liquidity ratios. The document is a procedural filing regarding the validity and underwriting of Notes rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this specific filing. The primary event is the execution of the Underwriting Agreement for the issuance of Notes.
Guidance, Outlook, and Legal Matters
The filing includes legal opinions from Jones Day regarding:
- The validity of the Notes under French law.
- The validity of the Notes under New York law.
- Certain matters of French taxation.
- Certain matters of U.S. taxation.
There is no management commentary, forward-looking guidance, or discussion of risks and contingencies within the text of this specific Form 6-K.
Investor Verification Checklist
- Verify the specific terms, interest rates, and maturity dates of the Notes referenced in the Underwriting Agreement (Exhibit 1.2).
- Confirm the total principal amount of the debt offering.
- Review the full Registration Statement on Form F-3 (No. 333-165479) for detailed financial data and risk factors not included in this summary.
- Check subsequent filings for the final closing of the offering and any changes to the underwriting structure.